中西医结合治疗老年风湿病的临床效果观察

Effect Observation of Integrated Chinese and Western Medicine in Elderly Rheumatism Patients

目的:浅析老年风湿病患者的治疗中应用中西医联合给药对总体疗效的促进价值。方法:筛选笔者所在医院收治的122例于2015年5月-2018年5月经确诊后入院接受治疗的风湿病老年患者纳入本次研究,并依照风湿病对症治疗差异作分组依据行对比论证,其中一组61例采用西药给药支持,为西医组,另一组61例采用中西医联合给药支持,为联合组。治疗结束后就两组患者的综合疗效、生活质量评估及疾病复发率行对比论证。结果:联合组在临床疗效、日常生活质量及1年内疾病复发率上均较西医组更优,比较差异有统计学意义(P<0.05)。结论:针对老年风湿病的治疗,中西联合可促疗效最大化,利于患者生活质量提升,复发率可控性好,值得临床推广。

Objective: To make a brief analysis of integrated Chinese and western medicine on the overall treatment efficacy for elderly rheumatism patients. Method: 122 elderly rheumatism patients treated from May 2015 to May 2018 in our hospital were selected. According to different therapies, patients were assigned to western medicine group(n=61, western medicine) and integrated group(n=61, integrated Chinese and western medicine). The overall treatment efficacy, quality of life and recurrence rate were compared. Result: The clinical treatment efficacy, quality of life and recurrence rate in 1 year of integrated group were better than those of western medicine group(P<0.05). Conclusion: The integrated Chinese and western medicine can maximize the treatment efficacy, improve the quality of life and reduce the recurrence rate. It is worthy of clinical promotion.